Midlife Serum Cholesterol and Increased Risk of Alzheimer’s and Vascular Dementia Three Decades Later
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Aims: To investigate midlife cholesterol in relation to Alzheimer’s disease (AD) and vascular dementia (VaD) in a large multiethnic cohort of women and men. Methods: The Kaiser Permanente Northern California Medical Group (healthcare delivery organization) formed the database for this study. The 9,844 participants underwent detailed health evaluations during 1964–1973 at ages 40–45 years; they were still members of the health plan in 1994. AD and VaD were ascertained by medical records between 1 January 1994 and 1 June 2007. Cox proportional hazards models – adjusted for age, education, race/ethnic group, sex, midlife diabetes, hypertension, BMI and late-life stroke – were conducted. Results: In total, 469 participants had AD and 127 had VaD. With desirable cholesterol levels (<200 mg/dl) as a reference, hazard ratios (HR) and 95% CI for AD were 1.23 (0.97–1.55) and 1.57 (1.23–2.01) for borderline (200–239 mg/dl) and high cholesterol (≥240 mg/dl), respectively. HR and 95% CI for VaD were 1.50 (1.01–2.23) for borderline and 1.26 (0.82–1.96) for high cholesterol. Further analyses for AD (cholesterol quartiles, 1st quartile reference) indicated that cholesterol levels >220 mg/dl were a significant risk factor: HR were 1.31 (1.01–1.71; 3rd quartile, 221–248 mg/dl) and 1.58 (1.22–2.06; 4th quartile, 249–500 mg/dl). Conclusion: Midlife serum total cholesterol was associated with an increased risk of AD and VaD. Even moderately elevated cholesterol increased dementia risk. Dementia risk factors need to be addressed as early as midlife, before underlying disease(s) or symptoms appear.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Findings in late-life cohorts vary, with some finding higher levels of cholesterol associated with a lower risk356 and others finding a higher risk for VaD.357”
In the citing paper
“there are several controllable risk factors including obesity [156,157], hyperlipidemia [158,159], hypertension [160,161,162,163], type 2 diabetes [164,165,166,167], and sedentary lifestyle [168] that can be addressed in an effort to decrease the risk of developing AD.”
From Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease (2020) · cites this paper as [158]
In the citing paper
“Obesity,71–73 dyslipidemia,74–77 and high BP78,79 are also major contributors to vascular brain health.”
From Defining Optimal Brain Health in Adults: A Presidential Advisory From the American Heart Association/American Stroke Association (2017) · cites this paper as [75]
Citations
Cites
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Hachinski, V., Iadecola, C., Petersen, R. C., Breteler, M. M., Nyenhuis, D. L., Black, S. E., Powers, W. J., DeCarli, C., Merino, J. G., Kalaria, R. N., et al. (2006) · Stroke · doi:10.1161/01.str.0000237236.88823.47 · Cited by 1,722 · cited 1×
“significantly increased the risk of developing VaD 3 decades later. High cholesterol levels (≥240 mg/dl) tended to increase VaD risk as well, but the association did not reach statistical significance. One reason for this could be the small sample size of VaD (127 persons in total, 39 with high cholesterol).VaD repres…”
BackgroundKrieger, N. (1992) · American Journal of Public Health · doi:10.2105/ajph.82.5.703 · Cited by 1,654 · cited 1×
“The present study investigates further the cholesterol-dementia relationship by focusing on the 2 main dementia subtypes, AD and vascular dementia (VaD), in a larger Kaiser Permanente cohort with updated follow-up information. We also examined the full range of cholesterol values (not just high cholesterol, >240 mg/dl…”
BackgroundMidlife cardiovascular risk factors and risk of dementia in late life
Whitmer, R. A., Sidney, S., Selby, J., Johnston, S. C., & Yaffe, K. (2005) · Neurology · doi:10.1212/01.wnl.0000149519.47454.f2 · Cited by 1,238 · cited 1×
“High midlife cholesterol has previously been shown to be a risk factor for dementia in the multiethnic cohort of women and men from the Kaiser Permanente Medical Care Program of Northern California [”
BackgroundSelf-citationKivipelto, M., Ngandu, T., Laatikainen, T., Winblad, B., Soininen, H., & Tuomilehto, J. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70537-3 · Cited by 1,126 · cited 1×
“Although our cohort does not include persons with mixed dementia as recognized by ICD-9 CM, the concomitant presence of neurodegenerative and vascular pathologies in a portion of the sample cannot be excluded. Clinical Significance and ConclusionsPhysicians tend to confine AD and VaD to geriatric age borders, and addr…”
ResultSelf-citationSerum Total Cholesterol, Apolipoprotein E {FC12}e4 Allele, and Alzheimer’s Disease
Notkola, I.-L., Sulkava, R., Pekkanen, J., Erkinjuntti, T., Ehnholm, C., Kivinen, P., Tuomilehto, J., & Nissinen, A. (1998) · Neuroepidemiology · doi:10.1159/000026149 · Cited by 669
Kivipelto, M., Helkala, E.-L., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Iivonen, S., Mannermaa, A., Tuomilehto, J., Nissinen, A., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-3-200208060-00006 · Cited by 645
Self-citationIribarren, C., Sidney, S., Sternfeld, B., & Browner, W. S. (2000) · JAMA · doi:10.1001/jama.283.21.2810 · Cited by 482
Kalmijn, S., Foley, D., White, L., Burchfiel, C. M., Curb, J. D., Petrovitch, H., Ross, G. W., Havlik, R. J., & Launer, L. J. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.10.2255 · Cited by 417 · cited 1×
“but no association was observed in the Honolulu Asia Aging Study (HAAS) or Framingham study [”
BackgroundCrossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain
BJÖRKHEM, I. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01725.x · Cited by 381
Cited by
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
“Midlife hypertension [51,60–62] and midlife high cholesterol [63,64] are also implicated as risk factors for dementia.”
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
2013 Alzheimer's disease facts and figures
Alzheimer's Association, Thies, W., & Bleiler, L. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.02.003 · Cited by 3,328
“These factors include smoking [29–31], obesity (especially in midlife) [32–37], diabetes mellitus [31,38–41], high cholesterol in midlife [34,42], and hypertension in midlife [34,37,43–45].”
2019 Alzheimer’s disease facts and figures.
Alzheimer's Association (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.01.010 · Cited by 2,461
2020 Alzheimer's disease facts and figures
(2020) · Alzheimer's & Dementia · doi:10.1002/alz.12068 · Cited by 2,353
2021 Alzheimer's disease facts and figures
(2021) · Alzheimer's & Dementia · doi:10.1002/alz.12328 · Cited by 2,201
2018 Alzheimer's disease facts and figures
Alzheimer's Association (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.001 · Cited by 1,912
“For example, in midlife, obesity [57,60–62], hypertension [57,63–67], prehypertension (systolic blood pressure from 120 to 139 mm Hg or diastolic pressure from 80 to 89 mm Hg) [67] and high cholesterol [68,69] are associated with an increased risk of dementia.”
2015 Alzheimer's disease facts and figures
Alzheimer's Association (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.02.003 · Cited by 1,635
2017 Alzheimer's disease facts and figures
(2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.02.001 · Cited by 1,311
2014 Alzheimer's disease facts and figures
Alzheimer's Association (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.02.001 · Cited by 1,020
“These factors include smoking [25–27], obesity (especially in midlife) [28–34], diabetes [27,35–39], high cholesterol in midlife [30,40], and hypertension in midlife [30,33,41–43].”
2012 Alzheimer's disease facts and figures Alzheimer's Association ∗
Thies, W., & Bleiler, L. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.02.001 · Cited by 982
2011 Alzheimer's disease facts and figures
Alzheimer's Association (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.02.004 · Cited by 908
2010 Alzheimer's disease facts and figures
Alzheimer's Association (2010) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.01.009 · Cited by 684
Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition
Gottesman, R. F., Schneider, A. L. C., Zhou, Y., Coresh, J., Green, E., Gupta, N., Knopman, D. S., Mintz, A., Rahmim, A., Sharrett, A. R., et al. (2017) · JAMA · doi:10.1001/jama.2017.3090 · Cited by 650
Biessels, G. J., Strachan, M. W. J., Visseren, F. L. J., Kappelle, L. J., & Whitmer, R. A. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70088-3 · Cited by 551
Self-citationStatins for the prevention of dementia
McGuinness, B., Craig, D., Bullock, R., & Passmore, P. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003160.pub3 · Cited by 490
BMI and risk of dementia in two million people over two decades: a retrospective cohort study
Qizilbash, N., Gregson, J., Johnson, M. E., Pearce, N., Douglas, I., Wing, K., Evans, S. J. W., & Pocock, S. J. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00033-9 · Cited by 475
Yaffe, K. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1481 · Cited by 445
Cardiovascular Risk Factors Promote Brain Hypoperfusion Leading to Cognitive Decline and Dementia
de la Torre, J. C. (2012) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2012/367516 · Cited by 440
“cholesterol, low density lipoprotein and triglycerides found in the blood of probable AD subjects [110].”
BackgroundGorelick, P. B., Furie, K. L., Iadecola, C., Smith, E. E., Waddy, S. P., Lloyd-Jones, D. M., Bae, H.-J., Bauman, M. A., Dichgans, M., Duncan, P. W., et al. (2017) · Stroke · doi:10.1161/str.0000000000000148 · Cited by 411
Pathology and pathogenesis of vascular cognitive impairment—a critical update
Jellinger, K. A. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00017 · Cited by 353
“Studies in middle-aged or older adults have found associations between VCI and hypertension (Kuller et al., 2005), hyperlipidemia (Solomon et al., 2009), diabetes (Ahtiluoto et al., 2010), obesity, and physical inactivity (Staekenborg et al., 2008).”
BackgroundDietary and lifestyle guidelines for the prevention of Alzheimer's disease
Barnard, N. D., Bush, A. I., Ceccarelli, A., Cooper, J., de Jager, C. A., Erickson, K. I., Fraser, G., Kesler, S., Levin, S. M., Lucey, B., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.033 · Cited by 339
Vascular Cognitive Impairment (VCI)
Rundek, T., Tolea, M., Ariko, T., Fagerli, E. A., & Camargo, C. J. (2022) · Neurotherapeutics · doi:10.1007/s13311-021-01170-y · Cited by 305
Genes associated with Alzheimer's disease: an overview and current status
Giri, M., Lü, Y., & Zhang, M. (2016) · Clinical Interventions in Aging · doi:10.2147/cia.s105769 · Cited by 311
Alzheimer’s Disease: An Update and Insights Into Pathophysiology
Abubakar, M. B., Sanusi, K. O., Ugusman, A., Mohamed, W., Kamal, H., Ibrahim, N. H., Khoo, C. S., & Kumar, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.742408 · Cited by 279
Cholesterol in the retina: The best is yet to come
Pikuleva, I. A., & Curcio, C. A. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.03.002 · Cited by 281
Midlife risk score for the prediction of dementia four decades later
Exalto, L. G., Quesenberry, C. P., Barnes, D., Kivipelto, M., Biessels, G. J., & Whitmer, R. A. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.05.1772 · Cited by 276
“Although the original CAIDE study used clinically established cut points, the current study had ample power for more discrete categorization of some continuous variables, and prior work in our population has shown associations with even moderately elevated vascular risk factors at midlife [18].”
Self-citationEffects of statins on mitochondrial pathways
Mollazadeh, H., Tavana, E., Fanni, G., Bo, S., Banach, M., Pirro, M., von Haehling, S., Jamialahmadi, T., & Sahebkar, A. (2021) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12654 · Cited by 249
“both Alzheimer’s disease and vascular dementia in hypercholesterolaemic patients after a three‐decade follow‐up.(145) Intriguingly, several case reports(146,147) and two randomized controlled trials(148,149) suggested a potential association between statin treatment and cognitive impairment, leading FDA to include in…”
BackgroundCognitive impairment six months after ischaemic stroke: a profile from the ASPIRE-S study
on behalf of the ASPIRE-S study group, Mellon, L., Brewer, L., Hall, P., Horgan, F., Williams, D., & Hickey, A. (2015) · BMC Neurology · doi:10.1186/s12883-015-0288-2 · Cited by 243
“A Finnish longitudinal cardiovascular risk factors study found that mid-life serum cholesterol levels were associated with an increased risk of vascular dementia and Alzheimer’s disease in later life, even after adjustment for statin therapy [37].”
BackgroundCritical window hypothesis of hormone therapy and cognition: a scientific update on clinical studies
Maki, P. M. (2013) · Menopause · doi:10.1097/gme.0b013e3182960cf8 · Cited by 242
Does vascular pathology contribute to Alzheimer changes?
Kalaria, R. N., Akinyemi, R., & Ihara, M. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.07.032 · Cited by 239
“Hypercholesterolemia in mid-life also tends to show positive association with dementia including AD and VaD [18–20] although cholesterol levels assessed in late life reveal less significant association with AD [21,22].”
BackgroundDementia, stroke, and vascular risk factors; a review
Sahathevan, R., Brodtmann, A., & Donnan, G. A. (2012) · International Journal of Stroke · doi:10.1111/j.1747-4949.2011.00731.x · Cited by 230
Cholesterol and Alzheimer’s Disease; From Risk Genes to Pathological Effects
Feringa, F. M., & van der Kant, R. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.690372 · Cited by 226
Anstey, K. J., Cherbuin, N., & Herath, P. M. (2013) · Prevention Science · doi:10.1007/s11121-012-0313-2 · Cited by 207
“Not high Reference 0 Anstey et al. 2008; Mielke et al. 2010; Solomon et al. 2009 High 0.41 3”
BackgroundMethodInfluentialBenefits of exercise training on cerebrovascular and cognitive function in ageing
Bliss, E. S., Wong, R. H., Howe, P. R., & Mills, D. E. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20957807 · Cited by 191
Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis
Wood, W. G., Li, L., Müller, W. E., & Eckert, G. P. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12637 · Cited by 194
“A modification of that hypothesis is the notion that high serum cholesterol levels during middle age are associated with an increased risk of AD (Solomon et al. 2009a).”
Dyslipidemia and the Risk of Alzheimer’s Disease
Reitz, C. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0307-3 · Cited by 190
Nutritional determinants of cognitive aging and dementia
Morris, M. C. (2012) · Proceedings of the Nutrition Society · doi:10.1017/s0029665111003296 · Cited by 186
Promoting Successful Cognitive Aging: A Ten-Year Update
Krivanek, T. J., Gale, S. A., McFeeley, B. M., Nicastri, C. M., & Daffner, K. R. (2021) · Journal of Alzheimer’s Disease · doi:10.3233/jad-201462 · Cited by 172
“[261], while other studies have found no link [263].”
ResultFerrer, I. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.03.005 · Cited by 174
“…systemic factors such as atherosclerosis and cardiovascular disease, elevated serum homocysteine and hypercholesterolemia at midlife, and family history of dementia (Qiu et al., 2005; Kivipelto and Solomon, 2006; Anstey et al., 2008; Solomon et al., 2009; Reitz et al., 2011; Ballard et al., 2011).”
BackgroundSaturated and trans fats and dementia: a systematic review
Barnard, N. D., Bunner, A. E., & Agarwal, U. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.02.030 · Cited by 172
“In a study of 9844 Kaiser Permanente patients, serum cholesterol levels drawn inmidlife (mean age 42 years) were associatedwith AD risk nearly 3 decades later (mean age 69 years) (Solomon et al., 2009).”
Hypoxia Due to Cardiac Arrest Induces a Time-Dependent Increase in Serum Amyloid β Levels in Humans
Zetterberg, H., Mörtberg, E., Song, L., Chang, L., Provuncher, G. K., Patel, P. P., Ferrell, E., Fournier, D. R., Kan, C. W., Campbell, T. G., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028263 · Cited by 173
“epidemiological studies linking cerebrovascular risk factors with AD [3,4,5,6].”
BackgroundGene-environment interactions in Alzheimer's disease: A potential path to precision medicine
Eid, A., Mhatre, I., & Richardson, J. R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.03.005 · Cited by 164
The 32-year relationship between cholesterol and dementia from midlife to late life
Mielke, M. M., Zandi, P. P., Shao, H., Waern, M., Östling, S., Guo, X., Björkelund, C., Lissner, L., Skoog, I., & Gustafson, D. R. (2010) · Neurology · doi:10.1212/wnl.0b013e3181feb2bf · Cited by 160
Prasanthi, J. R. P., Dasari, B., Marwarha, G., Larson, T., Chen, X., Geiger, J. D., & Ghribi, O. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.07.007 · Cited by 158
“Indeed, a recent epidemiological study on a large cohort of men and women demonstrated that high cholesterol levels during midlife was associated with a 66% increase in risk of developing AD late in life [6] and even borderline high levels of cholesterol were associated with increased risk of vascular dementia.”
BackgroundVascular Cognitive Impairment and Dementia
Wong, E. C., & Chui, H. C. (2022) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001124 · Cited by 216
Calabrese, V., Giordano, J., Signorile, A., Laura Ontario, M., Castorina, S., De Pasquale, C., Eckert, G., & Calabrese, E. J. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23925 · Cited by 157
Meng, X.-F., Yu, J.-T., Wang, H.-F., Tan, M.-S., Wang, C., Tan, C.-C., & Tan, L. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140954 · Cited by 150
Peters, D. G., Connor, J. R., & Meadowcroft, M. D. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.08.007 · Cited by 146
“AD is positively correlated with increased serum cholesterol (Solomon et al., 2009).”
BackgroundAssociation of midlife lipids with 20‐year cognitive change: A cohort study
Power, M. C., Rawlings, A., Sharrett, A. R., Bandeen‐Roche, K., Coresh, J., Ballantyne, C. M., Pokharel, Y., Michos, E. D., Penman, A., Alonso, A., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.07.757 · Cited by 146
Alzheimer's disease and diet: a systematic review
Yusufov, M., Weyandt, L. L., & Piryatinsky, I. (2017) · International Journal of Neuroscience · doi:10.3109/00207454.2016.1155572 · Cited by 140
Lyles, C. R. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.154 · Cited by 136
“Nephropathy No 14 576 (76) 11 857 (77) 2719 (72) Yes 4663 (24) 3616 (23) 1047 (28) Neuropathy No 4002 (21) 2822 (18) 1180 (31) Yes 15 237 (79) 12 651 (82) 2586 (69) MI No 18 346 (95) 14 816 (96) 3530 (94) Yes 893 (5) 657 (4) 236 (6) Retinopathy No 16 063 (83) 12 961 (84) 3102 (82) Yes 3176 (17) 2512 (16) 664 (18) Stro…”
β-Amyloid and the Pathomechanisms of Alzheimer’s Disease: A Comprehensive View
Penke, B., Bogár, F., & Fülöp, L. (2017) · Molecules · doi:10.3390/molecules22101692 · Cited by 132
“High cholesterol levels in midlife increase the risk of AD [107] and ApoE protein is the major cholesterol carrier.”
BackgroundChakrabarti, S., Kumar Khemka, V., Banerjee, A., Chatterjee, G., Ganguly, A., & Biswas, A. (2015) · Aging and disease · doi:10.14336/ad.2014.002 · Cited by 134
“[59] Solomon A, Kivipelto M, Wolozin B, Zhou J, Whitmer RA (2009).”
BackgroundMcCartney, D. L., Stevenson, A. J., Walker, R. M., Gibson, J., Morris, S. W., Campbell, A., Murray, A. D., Whalley, H. C., Porteous, D. J., McIntosh, A. M., et al. (2018) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2018.05.006 · Cited by 137
“Conflicting evidence exists for the association between mid-life levels of total cholesterol and dementia risk [38,39]; however, studies have consistently reported an inverse association between total cholesterol levels and AD risk in elderly individuals [40– 42].”
Sullivan, M. D., Katon, W. J., Lovato, L. C., Miller, M. E., Murray, A. M., Horowitz, K. R., Bryan, R. N., Gerstein, H. C., Marcovina, S., Akpunonu, B. E., et al. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1965 · Cited by 132
Vascular Cognitive Impairment: Disease Mechanisms and Therapeutic Implications
Levine, D. A., & Langa, K. M. (2011) · Neurotherapeutics · doi:10.1007/s13311-011-0047-z · Cited by 130
“Similarly, observational studies in middle-aged or older adults have found associations between VCI and hypertension [39, 40], hyperlipidemia [41], diabetes [27, 42], obesity [43], and physical inactivity [44], even when present later in life.”
BackgroundHypercholesterolaemia and vascular dementia
Appleton, J. P., Scutt, P., Sprigg, N., & Bath, P. M. (2017) · Clinical Science · doi:10.1042/cs20160382 · Cited by 126
Barberger-Gateau, P., Samieri, C., Feart, C., & Plourde, M. (2011) · Current Alzheimer Research · doi:10.2174/156720511796391926 · Cited by 126
“In epidemiological studies, there is an association between higher serum cholesterol levels in midlife and increased risk of AD [62-63] but this association was independent of ApoE genotype [62].”
BackgroundCholesterol impairs autophagy-mediated clearance of amyloid beta while promoting its secretion
Barbero-Camps, E., Roca-Agujetas, V., Bartolessis, I., de Dios, C., Fernández-Checa, J. C., Marí, M., Morales, A., Hartmann, T., & Colell, A. (2018) · Autophagy · doi:10.1080/15548627.2018.1438807 · Cited by 125
“In addition, retrospective epidemiological studies show that hypercholesterolemia in middle age is a risk factor for AD [31].”
BackgroundCholesterol and Late-Life Cognitive Decline
van Vliet, P. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-111028 · Cited by 126
Schilling, S., Tzourio, C., Soumaré, A., Kaffashian, S., Dartigues, J.-F., Ancelin, M.-L., Samieri, C., Dufouil, C., & Debette, S. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002265 · Cited by 119
The Role of microRNAs in Alzheimer’s Disease and Their Therapeutic Potentials
Miya Shaik, M., Tamargo, I., Abubakar, M., Kamal, M., Greig, N., & Gan, S. (2018) · Genes · doi:10.3390/genes9040174 · Cited by 115
24S-hydroxycholesterol in plasma: A marker of cholesterol turnover in neurodegenerative diseases
Leoni, V., & Caccia, C. (2012) · Biochimie · doi:10.1016/j.biochi.2012.09.025 · Cited by 128
Increased midlife triglycerides predict brain β-amyloid and tau pathology 20 years later
Nägga, K., Gustavsson, A.-M., Stomrud, E., Lindqvist, D., van Westen, D., Blennow, K., Zetterberg, H., Melander, O., & Hansson, O. (2018) · Neurology · doi:10.1212/wnl.0000000000004749 · Cited by 111
Vinuesa, Á., Pomilio, C. J., Gregosa, A., Bentivegna, M., Presa, J., Bellotto, M., Saravia, F., & Beauquis, J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.653651 · Cited by 122
Mechanistic Link between Vitamin B12 and Alzheimer’s Disease
Lauer, A. A., Grimm, H. S., Apel, B., Golobrodska, N., Kruse, L., Ratanski, E., Schulten, N., Schwarze, L., Slawik, T., Sperlich, S., et al. (2022) · Biomolecules · doi:10.3390/biom12010129 · Cited by 135
Association of Alzheimer disease pathology with abnormal lipid metabolism: The Hisayama Study
Matsuzaki, T., Sasaki, K., Hata, J., Hirakawa, Y., Fujimi, K., Ninomiya, T., Suzuki, S. O., Kanba, S., Kiyohara, Y., & Iwaki, T. (2011) · Neurology · doi:10.1212/wnl.0b013e31822e145d · Cited by 107
Prevention of Vascular Cognitive Impairment
Dichgans, M., & Zietemann, V. (2012) · Stroke · doi:10.1161/strokeaha.112.651778 · Cited by 107
“The rate of incident dementia was reduced by 50% (Figure 2), with most cases classified as AD.”
BackgroundInfluentialInvolvement of calpain in the neuropathogenesis of Alzheimer’s disease
Mahaman, Y. A. R., Huang, F., Kessete Afewerky, H., Maibouge, T. M. S., Ghose, B., & Wang, X. (2019) · Medicinal Research Reviews · doi:10.1002/med.21534 · Cited by 112
Duong, M. T., Nasrallah, I. M., Wolk, D. A., Chang, C. C. Y., & Chang, T.-Y. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.647990 · Cited by 105
Redox proteomics and amyloid β-peptide: Insights into Alzheimer disease
Butterfield, D. A., & Boyd‐Kimball, D. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14589 · Cited by 105
“2013), hyperlipidemia (Soloman et al. 2009; Meng et al. 2014), and hypertension (Launer et al.”
BackgroundThe effects of cholesterol on learning and memory
Schreurs, B. G. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.04.010 · Cited by 105
APP Function and Lipids: A Bidirectional Link
Grimm, M. O. W., Mett, J., Grimm, H. S., & Hartmann, T. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00063 · Cited by 104
Effect of western and high fat diets on memory and cholinergic measures in the rat
Kosari, S., Badoer, E., Nguyen, J. C. D., Killcross, S., & Jenkins, T. A. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.07.017 · Cited by 112
Impact of cardiovascular risk factors on cognitive function: The Tromsø study
Arntzen, K. A., Schirmer, H., Wilsgaard, T., & Mathiesen, E. B. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03263.x · Cited by 119
“Some cohort studies of aging populations found no effect [5] and even protective effects of cholesterol [28], but a study on 40–45-year-old subjects found that increasing cholesterol levels increased the risk of both vascular dementia and Alzheimer s disease three decades later [6], indicating a harmful effect of high…”
BackgroundWang, H.-L., Wang, Y.-Y., Liu, X.-G., Kuo, S.-H., Liu, N., Song, Q.-Y., & Wang, M.-W. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150734 · Cited by 99
“In another study conducted over a 30-year period, mid-life serum total cholesterol level is associated with an increased risk for AD [36].”
High-Density Lipoproteins and Cerebrovascular Integrity in Alzheimer’s Disease
Stukas, S. K., Robert, J., & Wellington, C. L. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.003 · Cited by 112
“…with decreased AD risk (Bonarek et al., 2000; Reitz et al., 2010; Zuliani et al., 2010), while hypercholesteremia is associated with an increased risk of AD (Kivipelto et al., 2001, 2002, 2005; Kuo et al., 1998; Lesser et al., 2001; Lesser et al., 2009; Notkola et al., 1998; Solomon et al., 2009).”
BackgroundKim, O. Y., & Song, J. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122356 · Cited by 102
The impact of alcohol on Alzheimer's disease: A systematic review
Piazza-Gardner, A. K., Gaffud, T. J. B., & Barry, A. E. (2013) · Aging & Mental Health · doi:10.1080/13607863.2012.742488 · Cited by 94
Cholesterol as a key player in amyloid β-mediated toxicity in Alzheimer’s disease
Rudajev, V., & Novotny, J. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.937056 · Cited by 94
“High plasma cholesterol, especially in midlife, perturbs cholesterol homeostasis and is considered a risk factor for AD (Kivipelto et al., 2001; Yaffe et al., 2002; Solomon et al., 2009; Ricciarelli et al., 2012; Tarawneh and Holtzman, 2012; Schilling et al., 2017; Wang et al., 2020).”
BackgroundGrant, W. B. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130719 · Cited by 92
Proitsi, P., Lupton, M. K., Velayudhan, L., Newhouse, S., Fogh, I., Tsolaki, M., Daniilidou, M., Pritchard, M., Kloszewska, I., Soininen, H., et al. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001713 · Cited by 91
“Epidemiological studies have shown associations between high cholesterol levels in midlife and LOAD risk [7–9], and statins have been shown to have a protective effect against the development of dementia [10–12].”
BackgroundCholesterol homeostasis: Researching a dialogue between the brain and peripheral tissues
Gliozzi, M., Musolino, V., Bosco, F., Scicchitano, M., Scarano, F., Nucera, S., Zito, M. C., Ruga, S., Carresi, C., Macrì, R., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105215 · Cited by 101
Genetic connections between neurological disorders and cholesterol metabolism
Björkhem, I., Leoni, V., & Meaney, S. (2010) · Journal of Lipid Research · doi:10.1194/jlr.r006338 · Cited by 94
Role of amyloid beta in lipid homeostasis
Grösgen, S., Grimm, M. O. W., Frieß, P., & Hartmann, T. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.05.002 · Cited by 90
Khan, M. A., Alam, Q., Haque, A., Ashafaq, M., Khan, M. J., Ashraf, G. M., & Ahmad, M. (2019) · Current Neuropharmacology · doi:10.2174/1570159x16666180828100002 · Cited by 91
“Clinical studies found that a slight increase in cholesterol level from borderline (greater than 220 mg/dl) could increase the risk of developing AD [57, 58].”
BackgroundMechanistic Link between Vitamin B12 and Alzheimer’s Disease
Lauer, A. A., Grimm, H. S., Apel, B., Golobrodska, N., Kruse, L., Ratanski, E., Schulten, N., Schwarze, L., Slawik, T., Sperlich, S., et al. (2022) · Publications of the UdS (Saarland University) · doi:10.22028/d291-35299 · Cited by 90
Visceral fat is associated with lower executive functioning in adolescents
Schwartz, D. H., Leonard, G. T., Perron, M., Richer, L., Syme, C. A., Veillette, S., Pausová, Z., & Paus, T. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.104 · Cited by 100
Does the oxysterol 27-hydroxycholesterol underlie Alzheimer's disease–Parkinson's disease overlap?
Marwarha, G., & Ghribi, O. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2014.09.013 · Cited by 87
“A report from an epidemiological study on a large cohort of women and men has demonstrated that high cholesterol levels during mid-life are associated with a 66% increase in AD risk late in life (Solomon et al., 2009).”
BackgroundKim, D. K., Han, D., Park, J., Choi, H., Park, J.-C., Cha, M.-Y., Woo, J., Byun, M. S., Lee, D. Y., Kim, Y., et al. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0326-z · Cited by 85
Wagner, M., Helmer, C., Tzourio, C., Berr, C., Proust-Lima, C., & Samieri, C. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.2004 · Cited by 86
Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease
Butterfield, D. A., & Boyd-Kimball, D. (2020) · Antioxidants · doi:10.3390/antiox9090818 · Cited by 85
Dasari, B., Prasanthi, J. R. P., Marwarha, G., Singh, B. B., & Ghribi, O. (2010) · BMC Ophthalmology · doi:10.1186/1471-2415-10-22 · Cited by 97
“Recent epidemiological studies have demonstrated that high plasma cholesterol levels are associated with a high risk for AD [17].”
BackgroundWee, J., Sukudom, S., Bhat, S., Marklund, M., Peiris, N. J., Hoyos, C. M., Patel, S., Naismith, S. L., Dwivedi, G., & Misra, A. (2023) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12395 · Cited by 82
The Impact of Cholesterol, DHA, and Sphingolipids on Alzheimer’s Disease
Grimm, M. O. W., Zimmer, V. C., Lehmann, J., Grimm, H. S., & Hartmann, T. (2013) · BioMed Research International · doi:10.1155/2013/814390 · Cited by 80
“Additionally, elevated 24OH-cholesterol levels were observed in the serum of AD patients [47].”
BackgroundAmyloid-β and Phosphorylated Tau are the Key Biomarkers and Predictors of Alzheimer’s Disease
Pradeepkiran, J. A., Baig, J., Islam, M. A., Kshirsagar, S., & Reddy, P. H. (2024) · Aging and Disease · doi:10.14336/ad.2024.0286 · Cited by 102
Li, J., Zhang, Y., Lu, T., Liang, R., Wu, Z., Liu, M., Qin, L., Chen, H., Yan, X., Deng, S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1037318 · Cited by 95
Diet’s Role in Modifying Risk of Alzheimer’s Disease: History and Present Understanding
Grant, W. B., & Blake, S. M. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230418 · Cited by 90
“Midlife moderate or high cholesterol increases AD risk by 50% and raises VaD risk [202].”
Grant, W. B. (2016) · Journal of the American College of Nutrition · doi:10.1080/07315724.2016.1161566 · Cited by 77
“Saturated fat Animal products are a source of saturated fat [75] Increases absorption of copper [64] Cholesterol Midlife total cholesterol is a risk factor for dementia/ AD [76]”
Background
Metadata
- Authors
- Solomon, A., Kivipelto, M., Wolozin, B., Zhou, J., & Whitmer, R. A.
- Affiliations
- University of Eastern Finland (FI)
- Boston University (US)
- Kaiser Permanente (US)
- Venue
- Dementia and Geriatric Cognitive Disorders
- Publisher
- S. Karger AG
- Published
- 2009
- Volume
- 28
- Issue
- 1
- Pages
- 75-80
- ISSN
- 1420-8008 (ISSN-L)
- 1421-9824
- PMC
- PMC2814023
- OpenAlex
- W2134458253
- Cited by
- 557
- References
- 22
- Citations by year
- 2026: 22 · 2025: 25 · 2024: 36 · 2023: 25 · 2022: 31 · 2021: 42 · 2020: 31 · 2019: 34 · 2018: 37 · 2017: 32 · 2016: 39 · 2015: 27 · 2014: 41 · 2013: 39 · 2012: 42
- FWCI
- 19.74
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Dementia and Geriatric Cognitive Disorders (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Kaiser Permanente
- National Institute of Diabetes and Digestive and Kidney Diseases (K01DK066308, DK066308)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- Alzheimer's disease, vascular dementia, dementia risk factors, total cholesterol, hypercholesterolemia, multi-ethnic cohort, men and women
- MeSH terms
- Adult, Aged, Alzheimer Disease, Cholesterol, Data Interpretation, Statistical, Female, Follow-Up Studies, Humans, Male, Middle Aged, Retrospective Studies, Socioeconomic Factors, Dementia, Vascular, Cohort Studies, Proportional Hazards Models, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.